| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8235991 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 6 Pages |
Abstract
Despite responses being obtained and ample use of surgery and reirradiation, second-line therapy with myeloablative schedules was not curative, barring a few exceptions. A salvage therapy for medulloblastoma after CSI still needs to be sought.
Keywords
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Maura M.D., Lorenza M.D., Filippo M.D., Veronica M.D., Roberto M.D., Paola M.D., Carlo N. M.D., Fabio M.D., Emanuele M.D., Graziella M.D., Geraldina M.D., Piergiorgio Ph.D., Luigi M.D., Paolo M.D., Marta M.D., Michela M.D., Emilia M.D., Stefania M.D.,